Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Elan Reports First Quarter 2008 Financial Results
- DUBLIN, Ireland -- Elan Corporation, plc today announced its first quarter 2008 financial results and provided a business update. Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "We continued to demonstrate successful execution and delivery of tangible results in the first quarter. We remain highly...
- Research articles 2008-04-24
- Elan Corp. plc is Added to the Bellwether Watch list.
- M2 PRESSWIRE-15 June 2007-Biotech News: Elan Corp. plc is Added to the Bellwether Watch listC1994-2007 M2 COMMUNICATIONS LTD RDATE:15062007 Elan Corp. plc (NYSE:ELN) is Added to the Bellwether Watch list Elan Corporation, plc operates as a neuroscience-based biotechnology company...
- Research articles 2007-06-15
- Stock Performance Since Earnings
- Hickey and Walters Bespoke submit: We recently calculated the performance of all US stocks since the open following their most recent earnings reports. This takes out the initial reaction to earnings reports in after-hours and pre-market trading and highlights how investors have treated shares post earnings. As shown...
- External links 2008-08-06
- Options Trader: Friday Outlook
- Phil Davis submits: Another week that flew by. by Philip Davis
- External links 2008-08-01
- Friday Options Update: ELN, BIIB, ANR, ORCL, MAR, A, IP, HBC, RKH
- Rebecca Engmann Darst contributed to this report. Elan ELN - “Weekus horribilis” for drugmaker Elan took hold today after its multiple-sclerosis drug Tysabri was implicated in new cases of a lethal brain infection. Coming hot on the heels of another product disappointment – underwhelming data on a much hoped-for Alzheimer’s...
- External links 2008-08-01
- Elan Reports Second Quarter 2007 Financial Results
- DUBLIN, Ireland -- Elan Corporation, plc today announced its second quarter 2007 financial results and provided a business update. Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "We continue to make progress in our pipeline and focus on moving our science towards the patients. Business...
- Research articles 2007-07-26
- Elan Reports Fourth Quarter and Full-Year 2007 Financial Results
- DUBLIN, Ireland -- Elan Corporation, plc today announced its full-year and fourth quarter 2007 financial results and provided guidance for its financial outlook for 2008. Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "Our key operating principles of patient focus, disciplined execution, and delivery of...
- Research articles 2008-02-13
- Elan Reports Fourth Quarter and Full-Year 2006 Financial Results
- DUBLIN, Ireland -- Elan Corporation, plc today announced its full-year and fourth quarter 2006 financial results and provided guidance for its financial outlook for 2007. Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "Elan's 2006 performance further demonstrates our focus on execution and the delivery...
- Research articles 2007-02-20
- Elan Reports Third Quarter 2007 Financial Results
- DUBLIN, Ireland -- Elan Corporation, plc today announced its third quarter 2007 financial results and provided a business update. Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "During the quarter we continued to make tangible progress within our pipeline and gaining momentum for Tysabri. Continued...
- Research articles 2007-10-25
- Elan Reports First Quarter 2007 Financial Results
- DUBLIN, Ireland -- Elan Corporation, plc today announced its first quarter 2007 financial results and provided a business update. Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "2007 started strongly in terms of revenue growth, operating improvements and continued advancements in the pipeline. Of particular...
- Research articles 2007-04-24
- Research and Markets: The Elan Corp Plc Competitor Report 2006 Delivers the Latest and the Most Comprehensive Intelligence Available On the Key Companies Active within Elan Corp Plcs Markets
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c49534) has announced the addition of Elan Corp Plc - Competitor Report to their offering
- Research articles 2007-01-30
- Elan Announces Resignation of Board Director
- DUBLIN, Ireland -- Elan Corporation, plc ("Elan") today announces the resignation of Nancy Lurker as a non-executive director of the Company with effect from May 31, 2006. Ms Lurker has been a director of Elan since May 2005. Ms Lurker this week announced that she will be taking up the...
- Research articles 2006-05-18
- Elan Corporation, PLC - Tysabri US Reintroduction FDA Approval Call - Research and Markets offers a transcript of 'Elan Corporation, PLC' Conference Call
- DUBLIN, Ireland -- The Elan Corporation, PLC (NYSE:ELN) Corporate Conference Call took place on 6-Jun-06 8:30am ET.
- Research articles 2006-06-06
- Research and Markets: Elan Corp Plc - Deals And Alliances Report Includes M&A Statistics And Recent Partnering News Updates By Date
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c49070) has announced the addition of "Elan Corp Plc - Deals and Alliances Report" to their offering.
- Research articles 2007-01-23
- Naked Short Web Site announces ELN, AMAC, ATPL, XCYT, IMX, have been removed from threshold lists today.
- M2 PRESSWIRE-6 June 2005-BUYINS.NET: Naked Short Web Site announces ELN, AMAC, ATPL, XCYT, IMX, have been removed from threshold lists todayC1994-2005 M2 COMMUNICATIONS LTD RDATE:06062005 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and...
- Research articles 2005-06-06
- Japanese Patent Office Issues Patent Certificate to Elan for Its NanoCrystal-TM- Technology
- DUBLIN, Ireland -- Elan Corporation, plc today announced that Japan's Patent Office has issued a patent certificate for Elan's proprietary NanoCrystalTM Technology. Japanese Patent Number 36020546, which expires January 24, 2012, protects intellectual property related to Elan's NanoCrystal technology. "This is a significant milestone in the development of new...
- Research articles 2005-02-03
- Elan to Present at the JP Morgan 23rd Annual Healthcare Conference
- DUBLIN, Ireland -- Elan Corporation, plc announces that it will present at the JP Morgan 23rd Annual Healthcare Conference in San Francisco on Tuesday, January 11, 2005 at 1.30 p.m. Pacific Standard Time, 4.30 p.m. Eastern Standard Time and 9.30 p.m. Greenwich Mean Time. Interested parties may access a live...
- Research articles 2005-01-05
- Elan Reports Third Quarter 2004 Financial Results
- DUBLIN, Ireland -- Elan Corporation, plc today announced its third quarter 2004 results and provided a business update. Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "All of our energies are focused on delivering our science to patients with unmet medical needs. Today, our...
- Research articles 2004-10-28
- Elan Completes Retirement of over $240 Million of 2008 Debt
- DUBLIN, Ireland -- Elan Corporation, plc today announced that it has completed the retirement of $242.8 million of its 2008 outstanding debt. As previously announced, Elan has purchased $206.0 million in aggregate principal amount of 6.5% Convertible Guaranteed Notes due 2008 issued by Elan Capital Corp Guaranteed Convertible Notes and...
- Research articles 2005-06-08
- Stull, Stull & Brody Announces Class Action against Elan Corporation, PLC
- NEW YORK -- Notice is hereby given that a class action lawsuit was filed on March 15, 2005 in the United States District Court for the Southern District of New York, against Elan Corporation, PLC ("Elan" or the "Company") (NYSE:ELN) on behalf of purchasers of Elan securities between February 18,...
- Research articles 2005-03-15
- << Previous
- page 1 of 6
- Next >>
Content Types
Refining Tags
- class action (12 results)
- Biogen Idec Inc. (9 results)
- Stock (9 results)
- Biotech (7 results)
- Finance (5 results)
- SEC (5 results)
- HEALTHCARE (5 results)
- IBM Lotus Notes (4 results)
- US Market (4 results)
- Johnson & Johnson (3 results)
- security (3 results)
- manufacturing (3 results)
- Nasdaq Stock Market Inc. (3 results)
- settlement (3 results)
